Alessandro Rametta

Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients

Arsela Prelaj, Edoardo Gregorio Galli, V. Miskovic et al. · Frontiers in Oncology · 2023 · 36 citations · Full text

Medicine, Immunology, Oncology +17

COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: the COVINT study

Federico Nichetti, Marta Bini, Margherita Ambrosini et al. · ESMO Open · 2020 · 18 citations · Full text

Medicine, Clinical Sciences, Oncology +14

The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma

Sebastiano Buti, Chiara Tommasi, Giulia Scartabellati et al. · Anti-Cancer Drugs · 2022 · 14 citations · Full text

Medicine, Oncology, Pharmacology +14

Neutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25)

Elisabetta Gambale, Marco Maruzzo, Carlo Messina et al. · Clinical Genitourinary Cancer · 2024 · 10 citations · Full text

Medicine, Oncology, Pharmacology +16